Search Results for 'Development'
Contract Service Directory Companies
Microsite Companies
Featured Companies
View All Buyers Guide Companies »
Contract Service Directory Categories
View All Categories »
-
Breaking News | Drug Development | Industry News
Bristol Myers Squibb Expands at Cambridge Crossing
Adds remaining 113,000 square feet to its initial lease at 250 Water Street.Kristin Brooks 04.16.21
-
Breaking News | Drug Development | Industry News
Amgen Completes Five Prime Acquisition
Gains pipeline of immuno-oncology and targeted cancer therapies, including a Phase 3 trial-ready, first-in-class program for gastric cancer.Kristin Brooks 04.16.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Sartorius Expands in the UK
New 58,000-square-foot facility aims to simplify and accelerate the production of downstream processing equipment.Kristin Brooks 04.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
Abenza Chooses North Carolina for New Biologics Manufacturing Site
GMP manufacturing will commence in mid-2022.Charles Sternberg, Assistant Editor 04.15.21
-
Breaking News | Collaborations & Alliances | Industry News | Solid Dosage/Creams/Ointments
Recro, Ensysce Expand Development and Manufacturing Partnership
Additional contract broadens and further strengthens customer product portfolio.Tim Wright, Editor, Contract Pharma 04.15.21
-
Breaking News | Industry News | Information Technology
Arkema Recruits Dotmatics as its R&D Digitalization Partner
Agreement supports Arkema’s project to modernize access to R&D data and reduce design times for new products.Charles Sternberg, Assistant Editor 04.15.21
-
Breaking News | Clinical Trial Materials | Industry News | Promotions & Moves | Solid Dosage/Creams/Ointments
Metrics Names Stephanie Emory Associate Director of Pharma Development
Will direct team of formulation scientists who develop oral solid dose formulations for Phase I through Phase III clinical trials.Tim Wright, Editor, Contract Pharma 04.15.21
-
Breaking News | Drug Development | Industry News
BioVersys Gets EIB Funds to Address Antimicrobial Resistance
Financing supports development of BioVersys’ breakthrough hospital antibiotic therapy targeting Acinetobacter baumanniiKristin Brooks 04.14.21
-
Breaking News | Industry News | Microbiology
Microbiologics Expands Virology Services
Increases capabilities and capacity to provide anti-infective testing, assay development and biomaterial production services for highly infectious pathogens.Kristin Brooks 04.14.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News | Information Technology
ATMPS, Ori Biotech Integrate Digital Platform for Cell & Gene Therapies
Aims to provide improved product tracking, scheduling and live monitoring of the manufacturing status across the entire CGT supply chain from vein to vein.Kristin Brooks 04.14.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Albumedix Completes Commercial-Scale Mfg. Facility Expansion
Will service increasing demand for products and technologies for cell and gene therapies, vaccines, diagnostics, protein and peptide therapeutics.Kristin Brooks 04.14.21
-
APIs | Drug Development | Process Validation
Exploring ICP-MS expertise at Almac
A discussion about Inductively Coupled Plasma Mass Spectrometry (ICP-MS) and its importance within drug development.
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Catalent Biologics Completes Madison Expansion
More than doubles overall CGMP-scale capacity increasing the number of manufacturing suites at the site to five.Kristin Brooks 04.13.21
-
Breaking News
Oxford Biomedica, Boehringer Sign Development & Supply Agreement
Intends to manufacture GMP batches for Boehringer Ingelheim to support the development of viral vectors.Charles Sternberg, Assistant Editor 04.13.21
-
Breaking News | Industry News | Microbiology
Lonza Expands PyroTec PRO for Endotoxin Testing
Aims to enable users to streamline and improve the performance of the QC laboratory, increasing lab efficiency and productivity.Kristin Brooks 04.12.21
-
Breaking News | Clinical Trials | Drug Development | Trials & Filings
FDA Accepts Airway Therapeutics’ IND for COVID Treatment
To initiate a Phase 1b trial to confirm the feasibility of intratracheal administrations of AT-100 and its beneficial safety and tolerability profile.Kristin Brooks 04.12.21
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Sanofi Invests in Cutting Edge Vax Production Site in Singapore
The factory will house several fully digitalized modules that allow production of three to four vaccines simultaneously.Kristin Brooks 04.12.21
-
R&D
Digitalization and the Future of Formulating in Modern R&D Labs
This webinar will focus on the benefits of implementing a true data infrastructure, and the challenges that organizations will face along this journey.04.12.21
-
Drug Delivery | Logistics | Vials
Vetter Packaging Solutions
Vetter can help you identify and develop the right packaging strategies for your compound, from clinical dev to commercialization to life cycle management.
-
Drug Delivery | Validation | Vials
Vetter Commercial Manufacturing
Vetter’s decades of experience as a contract manufacturer providing fill & finish for injectable drugs helps deliver results for both large and small companies.
-
Analytical Services | Drug Delivery | Lyophilization | Process Development | Validation
Vetter Development Service
With Vetter, you have a partner you can trust to support you throughout drug product development, clinical manufacturing and regulatory approval.
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Sanofi Acquires Tidal Therapeutics
Gains novel mRNA-based technology with research capabilities in immuno-oncology and inflammatory diseases, with potential in other disease areas.Kristin Brooks 04.12.21
-
Breaking News | Clinical Trials | CRO News | Industry News
Frontage Expands Capabilities at its Clinical Site in Secaucus, NJ
Offers full-service human absorption, metabolism, and excretion (hAME) studies with radiolabeled compounds.Tim Wright, Editor, Contract Pharma 04.09.21
-
Analytical Services | Breaking News | Clinical Trial Materials | Drug Development | Industry News
Ascendia Pharmaceuticals Poised for Expansion
CDMO secures growth equity investment from Signet Healthcare Partners.Tim Wright, Editor, Contract Pharma 04.09.21
-
Breaking News | Clinical Trials | CRO News
Merck KGaA Selects PRA’s Remote Patient Monitoring Platform
Adding layer of technology to HGH treatments aims to facilitate better patient compliance.Kristin Brooks 04.08.21
-
Analytical Services | Bioanalytical Services | Breaking News | Industry News
Agilex Biolabs Acquires TetraQ for APAC Expansion Plans
Specializes in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarker and immunological pharmacodynamics assessments.Kristin Brooks 04.08.21
-
Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Industry News
Alkermes, Merck Enter Clinical Trial and Supply Agreement
To evaluate nemvaleukin alfa in combination with Keytruda in patients with platinum-resistant ovarian cancer.Tim Wright, Editor, Contract Pharma 04.07.21
-
Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | Information Technology
Hitachi, Axcelead to Develop Next-Gen Biopharmaceuticals
Supporting R&D optimization of next-generation biopharmaceuticals with digital technology and drug discovery platform.Tim Wright, Editor, Contract Pharma 04.07.21
-
Breaking News | Collaborations & Alliances | Drug Delivery | Drug Development | Industry News
Kindeva Drug Delivery and Cambridge Healthcare Innovations Collaborate
Work together to develop and commercialize CHI’s novel dry-powder inhaler product.Charles Sternberg, Assistant Editor 04.07.21
-
Breaking News | Clinical Trials | Drug Development | Industry News
Sound Pharmaceuticals Receives $3.1M NIH Grant for COVID Treatment
To support the testing of SPI-1005 in two Phase 2 clinical trials for the treatment of COVID-19.Kristin Brooks 04.06.21
-
Breaking News | Clinical Trials | CRO News | Drug Development
Moleculin Selects IQVIA Biotech to Advance COVID Treatment
IQVIA to manage the company's effort to begin potential clinical trials of WP1122 for the treatment of COVID-19.Kristin Brooks 04.06.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Fill/Finish | Industry News
Moderna, Catalent Enter Long-Term Strategic Vax Pact
Catalent to dedicate a new high-speed vial filling line for the manufacture of the Moderna COVID-19 Vaccine and potentially other investigational programs.Kristin Brooks 04.06.21
-
Breaking News | Industry News | Promotions & Moves
Recro Pharma Expands Business Development Team
Adds six new members, including sales representatives and regional representatives.Charles Sternberg, Assistant Editor 04.05.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Parenterals
Sanofi to Build New $700M Flu Vaccine Facility in Canada
Facility will be located in Toronto and will increase supply of influenza vaccines in Canada, the U.S. and Europe.Tim Wright, Editor, Contract Pharma 04.05.21
-
Breaking News | Industry News | Information Technology
LabVantage Solutions Expands and Improves its Portfolio
Unveils two new solutions and an updated version of its flagship LIMS platform.Charles Sternberg, Assistant Editor 04.05.21
-
Bioanalytical Services | Breaking News | CRO News | Industry News
Charles River Acquires Retrogenix
Strengthens scientific expertise with the addition of cell microarray technology and off-target profiling for drug discovery.Tim Wright, Editor, Contract Pharma 04.05.21
-
Biologics, Proteins, Vaccines | Regulatory Affairs
What Will Change at FDA for 2021?
(R)evolution of the industry’s data, catalyzed by changes at FDA and what’s the likely impact to the pharmaceutical industry?Ben Locwin, Contributing Editor, International COVID-19 Advisor, Healthcare Futurist 04.01.21
-
Drug Delivery
The Ever-Evolving World of Combination Products
Looking at the benefits and challenges of the trend towards combination products.Ricki A. Chase, M.S, Lachman Consultants 04.01.21
-
Clinical Trials | Drug Development | QA/QC
RBQM Comes of Age: COVID as a Catalyst for Change
Clinical trial conduct has undergone a fundamental shift over the last year – and things will never be the same again.Online Exclusives Kristin Brooks, Managing Editor 04.01.21
-
R&D
Small Innovators & Niche CROs
Smaller CROs have the opportunity to provide a niche approach to its clients, particularly smaller sponsors who have shared synergies.Neil Goodman, David Bruce and Mohamed El Malt, Europital 04.01.21
-
Laboratory Testing
Focus on Science
How to maximize lab performance and value through comprehensive equipment management.Rohit Shroff, Senior Vice President, Global Lab Products, Avantor 04.01.21
-
Analytical Services | Bioanalytical Services | Laboratory Testing | R&D
Rapid and Data Rich Chromatographic Method Development
An overview of what to consider when developing chromatographic methods.Daniel Kirschner, Executive Director of Analytical Services, Cambrex - Durham, North Carolina 04.01.21
-
Laboratory Testing | R&D
How Modern Near-Infrared Came to Be
First region outside the visible to be discovered and last to be utilized.Gary E. Ritchie, Contributing Writer 04.01.21
-
Breaking News | Drug Development
Servier Acquires Agios Pharmaceuticals’ Oncology Portfolio
Expands its oncology leadership capabilities in the U.S.Charles Sternberg, Assistant Editor 04.01.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Eloxx Pharmaceuticals Acquires Zikani Therapeutics
Combined company brings complementary Ribosomal RNA-targeted genetic therapy platforms together.Kristin Brooks 04.01.21
-
Analytical Services | APIs | cGMP Manufacture | Excipients | Formulation Development | QA/QC | R&D | Solid Dosage/Semi-solids
Enteris BioPharma: Custom Solutions – From Bench to Market
CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.
-
Clinical Trial Materials | Drug Development | Formulation Development
On-Demand Webinar: Accelerated Timelines for Clinical Supply Manufacture
Watch this on-demand webinar to gain a deeper understanding of the value of adaptive processes at this critical early stage of drug development.
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Fill/Finish | Industry News
GSK Supports Manufacture of Novavax’ COVID-19 Vaccine
GSK will provide fill and finish manufacturing capacity for up to 60 million doses at its Barnard Castle facility.Tim Wright, Editor, Contract Pharma 03.31.21
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Ajinomoto, Bright Peak Enter Immunocytokines Research Pact
Exclusive license agreement to incorporate Ajinomoto Co.’s AJICAP site-specific bioconjugation technology for the development of Bright Peak Immunocytokines.Kristin Brooks 03.30.21
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News | Scale-up/Technology Transfer
CureVac, Celonic Enter COVID-19 Vax Mfg. Pact
Celonic is prepared to manufacture more than 100 million doses of CureVac’s mRNA-based COVID-19 vaccine candidate, CVnCoV, per year at Heidelberg facility.Kristin Brooks 03.30.21
